# Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis

> **NCT03599986** · — · COMPLETED · sponsor: **Eva Pharma** · enrollment: 398 (actual)

## Conditions studied

- Active Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03599986
- **Lead sponsor:** Eva Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-16
- **Primary completion:** 2018-10-13
- **Final completion:** 2018-10-13
- **Target enrollment:** 398 (ACTUAL)
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03599986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03599986, "Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03599986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*